Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that commonly occurs in men over age 50 due to hormonal changes and aging.
Common symptoms:
BPH presses on the urethra, causing lower urinary tract symptoms such as:
Causes and risk factors:
BPH treatment starts with watchful waiting for mild symptoms, progressing to medications, minimally invasive procedures, or surgery based on symptom severity, prostate size, and response to prior options.
Medications:
Alpha-blockers (e.g., tamsulosin, alfuzosin) relax prostate and bladder neck muscles for quicker urine flow improvement.
5-alpha reductase inhibitors (e.g., finasteride, dutasteride) shrink the prostate over months by blocking DHT hormone production, best for larger glands.
Combination therapy uses both for better symptom relief and reduced progression risk.
Minimally invasive procedures:
Surgical options:
Transurethral resection of the prostate (TURP) remains the gold standard, removing blocking tissue endoscopically; alternatives like holmium laser enucleation (HoLEP) or GreenLight laser suit larger prostates with less bleeding.